Cadherins E and P expression in the molecular types of breast cancer

被引:0
作者
Fernandez, Angel
Reigosa, Aldo
Caleiras, Eduardo [1 ]
Saldivia, Felipe [2 ]
Hardisson, David [3 ]
Sanz, Francisco [4 ]
机构
[1] Hosp Metropolitano Norte, Unidad Diagnost Anatomopatol, Valencia, Venezuela
[2] Inst Oncol Dr Miguel Perez Carreno, Valencia, Venezuela
[3] Univ Autonoma Madrid, Fac Med, Dept Anat Patol, E-28049 Madrid, Spain
[4] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain
来源
INVESTIGACION CLINICA | 2015年 / 56卷 / 02期
关键词
cadherin E; cadherin P; molecular class; epithelial-mesenchymal transition; breast cancer; EPITHELIAL-MESENCHYMAL TRANSITION; BASAL-LIKE PHENOTYPE; ESTROGEN-RECEPTOR; TUMOR PROGRESSION; STEM-CELLS; SUBTYPES; CARCINOMA; THERAPY; PROGNOSIS; SURVIVAL;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The epithelial-mesenchymal transition is a process by which tumor cells lose their epithelial markers and migrate to distant organs. This process involves several cell adhesion proteins such as E-cadherin and P-cadherin. The present study was performed in 354 pacients diagnosed with breast infiltrating ductal carcinoma in the Oncology Institute "Dr. Miguel Perez Carrerno", Valencia, Venezuela. The expression of 22 molecules was analyzed by tissue micro-arrays and the results were compared with the molecular clases established by immunohistochemistry, according to the expression of estrogen receptor (ER), progesterone (PR) and human epidermal growth factor receptor type 2 (HER2), and with the overall survival (OS). Based on the results of ER, PR and HER2 molecular classes according to the following percentages were established: Luminal A 42.4%, Luminal B 20.3%, 9% HER2 and 28.2% triple negative (TN). E-cadherin expression was observed conserved in most of the tumors of this series, 92.5% of cases. TN phenotype tumors showed a high percentage (41.7%) with absent or reduced expression. The P-cadherin was expressed in 40.5% of cases, although expressed in all classes; the proportion was significantly higher in cases TN. No significant prognostic value was observed when analyzing the overall five-year survival of patients with tumors with absent or reduced expression of E-cadherin. The P-cadherin expression had a negative relationship with the OS.
引用
收藏
页码:155 / 168
页数:14
相关论文
共 50 条
[21]   New Fluorescent Reporter Systems for Evaluation of the Expression of E- and N-Cadherins [J].
Burmistrova, O. A. ;
Nikulin, S. V. ;
Zakharova, G. S. ;
Fomicheva, K. A. ;
Alekseev, B. Ya. ;
Shkurnikov, M. Yu. .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 165 (01) :88-93
[22]   Cyclin E expression and proliferation in breast cancer [J].
Nielsen, NH ;
Arnerlöv, C ;
Cajander, S ;
Landberg, G .
ANALYTICAL CELLULAR PATHOLOGY, 1998, 17 (03) :177-188
[23]   MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer [J].
Han, Song-Hee ;
Kim, Hyun Jeong ;
Gwak, Jae Moon ;
Kim, Mimi ;
Chung, Yul Ri ;
Park, So Yeon .
JOURNAL OF BREAST CANCER, 2017, 20 (01) :35-44
[24]   Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis [J].
Qiao, Weiqiang ;
Liu, Heyang ;
Guo, Wanying ;
Li, Peng ;
Deng, Miao .
EJSO, 2019, 45 (07) :1132-1137
[25]   Nuclear Expression of p-STAT3 Is Associated with Poor Prognosis in ER(-) Breast Cancer [J].
Nakagawa, Tsuyoshi ;
Oda, Goshi ;
Kawachi, Hiroshi ;
Ishikawa, Toshiaki ;
Okamoto, Kentaro ;
Uetake, Hiroyuki .
CLINICS AND PRACTICE, 2022, 12 (02) :157-167
[26]   Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins [J].
Xu, Mingfei ;
Liu, Chaoyue ;
Pu, Lulan ;
Lai, Jinrong ;
Li, Jingjia ;
Ning, Qianwen ;
Liu, Xin ;
Deng, Shishan .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (15) :1706-1720
[27]   The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches [J].
Cruceriu, Daniel ;
Baldasici, Oana ;
Balacescu, Ovidiu ;
Berindan-Neagoe, Ioana .
CELLULAR ONCOLOGY, 2020, 43 (01) :1-18
[28]   Neuroendocrine pathways and breast cancer progression: a pooled analysis of somatic mutations and gene expression from two large breast cancer cohorts [J].
Hu, Kejia ;
Wang, Chengshi ;
Luo, Chuanxu ;
Zheng, Hong ;
Song, Huan ;
Bergstedt, Jacob ;
Fall, Katja ;
Luo, Ting ;
Czene, Kamila ;
Valdimarsdottir, Unnur A. ;
Fang, Fang ;
Lu, Donghao .
BMC CANCER, 2022, 22 (01)
[29]   Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases [J].
Eduardo, Mariana Bustamante ;
Popovici, Vlad ;
Imboden, Sara ;
Aebi, Stefan ;
Ballabio, Nadja ;
Altermatt, Hans Jorg ;
Gunthert, Andreas ;
Jaggi, Rolf .
BMC CANCER, 2019, 19 (1)
[30]   E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis [J].
Liu, Jiang-Bo ;
Feng, Chen-Yi ;
Deng, Miao ;
Ge, Dong-Feng ;
Liu, De-Chun ;
Mi, Jian-Qiang ;
Feng, Xiao-Shan .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15